USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis
Publication year
2012Source
Journal of Clinical Investigation, 122, 12, (2012), pp. 4362-74ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Cell Biology (UMC)
Journal title
Journal of Clinical Investigation
Volume
vol. 122
Issue
iss. 12
Page start
p. 4362
Page end
p. 74
Subject
NCMLS 4: Energy and redox metabolism IGMD 8: Mitochondrial medicineAbstract
Most human tumors have abnormal numbers of chromosomes, a condition known as aneuploidy. The mitotic checkpoint is an important mechanism that prevents aneuploidy by restraining the activity of the anaphase-promoting complex (APC). The deubiquitinase USP44 was identified as a key regulator of APC activation; however, the physiological importance of USP44 and its impact on cancer biology are unknown. To clarify the role of USP44 in mitosis, we engineered a mouse lacking Usp44. We found that USP44 regulated the mitotic checkpoint and prevented chromosome lagging. Mice lacking Usp44 were prone to the development of spontaneous tumors, particularly in the lungs. Additionally, USP44 was frequently downregulated in human lung cancer, and low expression correlated with a poor prognosis. USP44 inhibited chromosome segregation errors independent of its role in the mitotic checkpoint by regulating centrosome separation, positioning, and mitotic spindle geometry. These functions required direct binding to the centriole protein centrin. Our data reveal a new role for the ubiquitin system in mitotic spindle regulation and underscore the importance of USP44 in the pathogenesis of human cancer.
This item appears in the following Collection(s)
- Academic publications [242559]
- Electronic publications [129511]
- Faculty of Medical Sciences [92283]
- Open Access publications [104133]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.